On April 23, 2024, INTCO Medical released its 2024 Environmental, Social, and Governance (ESG) Report — the fourth ESG disclosure since the company began publishing such reports. As a global leader in medical consumables, INTCO Medical remains committed to its mission: “Global INTCO Global Health”. By leveraging technological innovation and embracing green initiatives, the company continuously upgrades its industrial capabilities while pursuing sustainable development in cooperation with global partners.

Our Footprint in Sustainability

Environmental Performance (E)

In 2024, INTCO Medical made significant strides in environmental responsibility by reducing its carbon footprint and conserving resources. The carbon emissions per glove dropped to 20.41 grams, a 20.70% decrease from the previous year. Water consumption per glove was reduced to 0.21 liters, down 11.02% year-on-year. The company also generated a total of 3,538,596.60 kWh of photovoltaic power throughout the year. Meanwhile, carbon emissions for healthcare and rehabilitation products were kept below 5800 metric tons of CO₂ equivalent.

Social Performance (S)

INTCO Medical’s global workforce totaled 10,982 employees in 2024. R&D investment reached RMB 398 million, reflecting a strong commitment to innovation. Women made up 60.23% of the workforce, while 33.60% of managerial roles were held by women. The company continued to improve its employee training system, with an average training duration of 36.02 hours per employee and 100% training coverage.

Governance Performance (G)

The company maintained strong governance standards, enhancing transparency and professionalism. Independent directors made up 42.86% of the board, with women also holding 42.86% of board positions. In 2024, INTCO conducted five risk control training sessions and seven cybersecurity workshops, reaching 1,898 participants across its workforce.

ESG Awards and Recognitions in 2024

Throughout 2024, INTCO Medical received multiple accolades for its ESG performance, further solidifying its market reputation. The company earned an A rating from WIND, a BBB rating from MSCI ESG, and was awarded the EcoVadis “COMMITTED” badge. It also successfully passed both the WRAP (Worldwide Responsible Accredited Production) and BSCI (Business Social Compliance Initiative) certifications.

INTCO Medical received 16 ESG-related awards in total, including prestigious titles such as “Top 20 ESG Performers among A-share Listed Medical Device Companies” and the “ESG Golden Bull Award – Top 20 in Governance”, highlighting its continued efforts and outstanding achievements in sustainable development.

A Pioneer in Innovation

Driven by the belief in “Meet human health needs by the achievement of human wisdom,” INTCO Medical considers technological innovation the core driver of its business growth. In 2024, the company enhanced its R&D capabilities and reinforced product safety and quality controls to deliver high-quality, reliable products and services to global customers.

By the end of 2024, INTCO employed 1,202 R&D staff, representing 10.95% of the total workforce. R&D investment reached RMB 397 million. During the reporting period, 55 new products remained in continuous production — a 197% increase compared to 2023. The company also expanded into five new product application areas: food processing, retail, pharmaceutical labs, clean electronics, and e-commerce.

In addition, INTCO filed 43 new patent applications and received 33 new patent grants, bringing its cumulative authorized patents to 282.

Leading the Green Transition

Green development is a cornerstone of high-quality growth. In response to China’s “dual carbon” strategy, INTCO Medical continues to promote environmentally responsible practices through its “green, healthy, safe, energy-saving, and lean” philosophy. In 2024, the company achieved 100% compliance in both wastewater and waste gas discharge standards.

A major milestone in clean energy was the initiation of wind power infrastructure at the HuaiBei manufacturing base in Anhui Province, with the wind energy system expected to be operational in 2025.

In sustainable packaging, the company optimized its original full-sheet packaging into a two-piece design, reducing paper usage by approximately 80%. Over 11.1 million units of products used FSC-certified packaging materials, representing a 77.73% increase from 2023.

Practicing Responsible Procurement

INTCO Medical places high priority on maintaining a stable and sustainable supply chain. The company enforces dynamic supplier management, robust procurement standards, and clear evaluation metrics, encouraging suppliers to adopt environmentally and socially responsible practices.

By the end of 2024, the company had 3,900 Class A suppliers, 30 Class B, and 9 Class C suppliers. It upgraded its Supplier Relationship Management (SRM) system and issued a new framework for Procurement Strategy Formulation and Management.

In 2024, INTCO conducted 198 supply chain training sessions, with 1,800 suppliers participating. It also hosted 268 technical workshops, involving 780 suppliers.

Championing Quality of Life

INTCO Medical is committed to making healthcare more accessible and equitable. The company develops a diverse range of rehabilitation equipment and engages in public welfare to improve the lives of vulnerable groups. Guided by its core values — “Love, Kindness, and Truth” — INTCO Medical co-founded the Shanghai INTCO Foundation in 2020 with INTCO Recycling to support long-term social welfare initiatives.

In 2024, INTCO donated RMB 2.82 million to a wide range of charitable causes, including poverty alleviation, community development, education support, and disaster relief, advancing its commitment to social sustainability through concrete actions.

Advocating a People-Centered Culture

Recognizing talent as its most valuable asset, INTCO Medical strives to foster a fair, inclusive, and respectful workplace. It continuously refines compensation structures, employee welfare systems, and career development pathways, ensuring occupational health and safety while enabling personal growth.

By the end of 2024, the company had 10,982 full-time employees, including 6,614 women (60.23%), 162 minority employees, and 120 employees with disabilities. Women held 33.6% of management roles, with 22.7% in senior management. Among STEM positions, 228 employees were women, and in sales-related managerial positions, women accounted for 35.3%.

Through initiatives like competitive selection programs and performance-based advancement, the company is building a digital HR system and organizing monthly team-building activities at each facility to strengthen employee engagement and cohesion.

Building a Resilient Governance System

INTCO Medical is committed to enhancing its corporate governance by optimizing its “three meetings and one layer” structure (shareholders’ meetings, board meetings, supervisory board, and executive management), ensuring shareholder rights, and promoting ethical, efficient, and stable operations.

In 2024, the company convened five shareholder meetings, reviewing 19 proposals; nine board meetings to discuss 33 proposals; and ten specialized committee meetings to review 23 proposals. Investor relations were a focus, with INTCO participating in 2 earnings briefings, 30 broker strategy sessions, 112 one-on-one institutional roadshows, and handling over 1,500 investor hotline calls.

The company enforces a zero-tolerance policy toward bribery and corruption. In 2024, it conducted five business ethics and anti-corruption training sessions, engaging over 1,000 employees. Risk management was reinforced through diversified training programs that boosted employees’ risk awareness and response capabilities.

In terms of cybersecurity, INTCO held seven information and network security training sessions, reaching 1,898 participants with a total training time of 34.5 hours, averaging 4.9 hours per participant.

Looking Ahead to 2025: Shaping a Sustainable Future Together

As we move into 2025, INTCO Medical will continue to uphold the principles of sustainable development, align with national strategies, and contribute to the vision of “Healthy China” through high-quality growth. By strengthening collaboration with global supply chain partners, customers, and stakeholders, INTCO remains committed to co-creating value, embracing responsibility, and advancing human health through a green, efficient, and accountable development path.